Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AVITA Medical (RCEL) EBT (2018 - 2025)

AVITA Medical filings provide 8 years of EBT readings, the most recent being -$11.6 million for Q4 2025.

  • On a quarterly basis, EBT fell 0.7% to -$11.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$48.6 million, a 21.37% increase, with the full-year FY2025 number at -$48.6 million, up 21.37% from a year prior.
  • EBT hit -$11.6 million in Q4 2025 for AVITA Medical, up from -$13.2 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $37.6 million in Q4 2023 to a low of -$18.6 million in Q1 2024.
  • Median EBT over the past 5 years was -$9.7 million (2022), compared with a mean of -$7.7 million.
  • Biggest five-year swings in EBT: surged 788.84% in 2023 and later tumbled 130.71% in 2024.
  • AVITA Medical's EBT stood at -$5.9 million in 2021, then grew by 8.04% to -$5.5 million in 2022, then soared by 788.84% to $37.6 million in 2023, then tumbled by 130.71% to -$11.6 million in 2024, then dropped by 0.7% to -$11.6 million in 2025.
  • The last three reported values for EBT were -$11.6 million (Q4 2025), -$13.2 million (Q3 2025), and -$9.9 million (Q2 2025) per Business Quant data.